Description

Advanced Defense Against Resistant Infections

Revlin Injection contains Tigecycline, a next-generation antibiotic designed to combat multi-drug-resistant bacteria with precision and reliability.

⚡ Broad-Spectrum Power

• Effective against Gram-positive, Gram-negative & anaerobic pathogens
• Active against drug-resistant organisms, including MRSA and VRE
• Ideal for complicated and severe infections

🔬 Mechanism of Action

• Inhibits bacterial protein synthesis
• Prevents growth and spread of resistant pathogens
• Ensures bacteriostatic control in difficult infections

🏥 Key Indications

• Complicated Intra-abdominal Infections (cIAI)
• Complicated Skin & Soft Tissue Infections (cSSTI)
• Community-acquired Pneumonia
• Infections caused by resistant organisms

💡 Why Choose Revlin?

• Designed for multi-drug-resistant infections
• Effective where conventional antibiotics fail
• Trusted in hospital and critical care settings

👉 Revlin – Redefining Control Over Resistant Infections.